Journal Article (387)
381.
Journal Article
130B (1), pp. 67 - 68 (2004)
Polymorphisms in serotonin receptor genes HTR1B, HTR2A, HTR2C and HTR4 are possibly associated with specific personality traits in patients suffering from anxiety disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 382.
Journal Article
62 (9), pp. 1619 - 1622 (2004)
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 383.
Journal Article
36, pp. 1319 - 1325 (2004)
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genetics 384.
Journal Article
74 (1), pp. 11 - 19 (2004)
The PARK8 locus in autosomal dominant parkinsonism: Confirmation of linkage and further delineation of the disease-containing interval. American Journal of Human Genetics 385.
Journal Article
36 (5), p. 239 - 239 (2003)
Is there a genetic continuum between anxiety and depression? Pharmacopsychiatry 386.
Journal Article
36 (5), pp. 252 - 253 (2003)
HPA axis dysregulation and suicidal behavior in depression - Differentiation of a genetically distinct subgroup? Pharmacopsychiatry 387.
Journal Article
36 (5), p. 273 - 273 (2003)
Evidence for genetic heterogeneity in Restless Legs Syndrome. Pharmacopsychiatry Book Chapter (3)
388.
Book Chapter
Statistical genetics: genome-wide studies. In: Psychiatric genetics: a primer for clinical and basic scientists, pp. 57 - 69 (Eds. Schulze, T. G.; McMahon, F. J.). Oxford Univ. Press, New York (2018)
389.
Book Chapter
From Epigenetic Associations to Biological and Psychosocial Explanations in Mental Health. In: NEUROEPIGENETICS AND MENTAL ILLNESS, pp. 299 - 323 (Ed. Rutten, B. P. F.). ELSEVIER ACADEMIC PRESS, Cambridge (2018)
390.
Book Chapter
Genetische Grundlagen der Wirksamkeit von Antidepressiva. Forschungsbericht 2006 - Max-Planck-Institut für Psychiatrie. In: Jahrbuch (Ed. Max-Planck-Gesellschaft). Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., München (2006)
Conference Paper (9)
391.
Conference Paper
42 (7), 41, pp. 701 - 702 (2018)
How well can we classify coronary artery disease using all genetic data and choosing the best classification algorithm? 27th Annual Meeting of the International Genetic Epidemiology Society (IGES), San Diego, USA, October 14, 2018 - October 16, 2018. GENETIC EPIDEMIOLOGY 392.
Conference Paper
27 (S3), pp. S395 - S396 (2017)
USING POLYGENIC SCORES BASED ON SCHNEIDERIAN FIRST RANK SYMPTOMS TO CHARACTERIZE DISEASE TRAJECTORIES IN SEVERE MENTAL ILLNESSES. 24th World Congress of Psychiatric Genetics (WCPG 2016), Jerusalem, ISRAEL, October 30, 2016 - November 04, 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 393.
Conference Paper
27 (S3), M28, pp. S385 - S386 (2017)
POLYGENIC RISK FOR BIP, MDD, AND SCZ IN ANDALUSIAN MULTIPLEX FAMILIES. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, October 30, 2016 - November 04, 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 394.
Conference Paper
27 (S3), p. S486 - S486 (2017)
POLYGENIC SCORES DERIVED FROM NEUROIMAGING ENDOPHENOTYPES PREDICT OUTCOMES TO PSYCHOTHERAPY AND MEDICATION TREATMENTS FOR MAJOR DEPRESSIVE DISORDER. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, October 30, 2016 - November 04, 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 395.
Conference Paper
27 (Suppl.2), Su19, pp. S217 - S218 (2017)
GENOME-WIDE ASSOCIATION STUDY OF PANIC DISORDER. 23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, CANADA, October 16, 2015 - October 20, 2015. EUROPEAN NEUROPSYCHOPHARMACOLOGY 396.
Conference Paper
27 (Suppl. 3), T24, pp. S446 - S447 (2017)
SEX-SPECIFIC DNA METHYLATION SIGNATURES IN PANIC DISORDER. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, October 30, 2016 - November 04, 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 397.
Conference Paper
27 (Suppl. 2), Sa68, pp. S183 - S184 (2017)
IDENTIFICATION OF GENETIC INTERACTIONS INVOLVED IN DYSLEXIA PATHOGENESIS. 23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, CANADA, October 16, 2015 - October 20, 2015. EUROPEAN NEUROPSYCHOPHARMACOLOGY 398.
Conference Paper
124 (10), p. 1292 - 1292 (2017)
Aging- and stress-related epigenetic disinhibition of FKBP5 contributes to NF-κB-driven inflammation and cardiovascular risk. Conference of the World-Association-for-Stress-Related-and-Anxiety-Disorders (WASAD), Würzburg, Germany, September 14, 2017 - September 16, 2017. JOURNAL OF NEURAL TRANSMISSION 399.
Conference Paper
42 (Suppl. 1), T26, pp. S310 - S311 (2017)
Aging- and Stress-Related Epigenetic Disinhibition of FKBP5 Contributes to NF-KB-Driven Inflammation and Cardiovascular Risk. 56th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP), Palm Springs, CA, December 03, 2017 - December 07, 2017. NEUROPSYCHOPHARMACOLOGY Meeting Abstract (27)
400.
Meeting Abstract
31, p. 341 - 341. (2023)
Large-scale genomic meta-analysis on math abilities in cohorts of 20,000 participants. In EUROPEAN JOURNAL OF HUMAN GENETICS,